| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/09/1993 | US5185352 Alkoxy-4(1h)-pyridone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 02/09/1993 | US5185321 Adding lysozyme to Lactobeicillus, incubating, hydrolyzing peptidoglycans, centriguging, adding to whey or fermented milk |
| 02/09/1993 | CA2075673A1 (2-alkyl-3-pyridyl)methylpiperazine derivatives |
| 02/04/1993 | WO1993002203A1 Fr901451 substance, process for preparation thereof and use thereof |
| 02/04/1993 | WO1993002191A1 Humanized antibody against cd18 |
| 02/04/1993 | WO1993002108A1 Recombinant antibodies for human therapy |
| 02/04/1993 | WO1993002081A1 Novel benzopyrido piperylidene compounds, compositions, methods of manufacture and methods of use |
| 02/04/1993 | WO1993001831A1 Induction of cytotoxic t-lymphocyte responses |
| 02/04/1993 | WO1993001815A1 Drug for preventing and/or treating allergic disease |
| 02/04/1993 | WO1993001813A1 Platelet activating factor antagonists |
| 02/04/1993 | WO1993001717A1 Modulation and diagnosis of cytokine dysfunctions |
| 02/04/1993 | WO1992013950A3 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/04/1993 | CA2114009A1 Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use |
| 02/04/1993 | CA2113720A1 Induction of cytotoxic t-lymphocyte responses |
| 02/04/1993 | CA2113573A1 Modulation and diagnosis of cytokine dysfunctions |
| 02/04/1993 | CA2112562A1 Platelet activating factor antagonists |
| 02/03/1993 | EP0526402A1 Heteroaryl substituted hydroxylamine derivatives as lipoxygenase inhibitors |
| 02/03/1993 | EP0526395A1 Arylalkylamine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/03/1993 | EP0526192A2 Hexapeptide |
| 02/03/1993 | EP0526004A1 Pyrazolopyrimidinone antianginal agents |
| 02/03/1993 | EP0525917A2 Double-stranded RNA correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles |
| 02/03/1993 | EP0525573A1 Organogermanium and organosilicon compounds, process for the preparation of the same and use thereof |
| 02/03/1993 | EP0525571A1 Quinolin-2-yl-methoxybenzylhydroxyureas as lipoxygenase inhibitors |
| 02/03/1993 | EP0525420A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors |
| 02/03/1993 | EP0525002A1 2[5H]-FURANONES SUBSTITUTED IN THE 3 POSITION, AS Ca 2+ CHANNEL ANTAGONISTS AND ANTI-INFLAMMATORY AGENTS |
| 02/03/1993 | CN1068570A Antiviral combinations |
| 02/02/1993 | US5183826 Antiviral agent |
| 02/02/1993 | US5183667 Treating tumor disease by administering culture product containing beta-glucan |
| 02/02/1993 | CA2074861A1 Microorganism for producing c-31 desmethyl fr-900520 cyclic hemiketal immunosuppressant agent |
| 02/02/1993 | CA2074856A1 C-31 desmethyl fr-900520 cyclic hemiketal immunosuppressant agent |
| 02/01/1993 | CA2074788A1 Qinolin-2-yl-methoxybenzylhydroxyureas |
| 01/31/1993 | CA2074967A1 Hexapeptide |
| 01/31/1993 | CA2074797A1 Certain heteroaryl substituted hydroxylamine derivatives |
| 01/27/1993 | EP0524899A1 Recombinant DNA molecules coding for the VB2 T cell receptor, method of preparation, antibodies and medicaments containing them |
| 01/27/1993 | EP0524834A2 Immunosuppressive drugs containing a cysteine protease |
| 01/27/1993 | EP0524796A1 Use of essential fatty acids in the preparation of a medicament for the treatment of AIDS |
| 01/27/1993 | EP0524784A1 Benzopyrido piperidylidene compounds as PAF antagonists |
| 01/27/1993 | EP0524517A1 Substituted 3,4-dihydronaphthalenes, medicament containing them and process for their preparation |
| 01/27/1993 | CN1068334A Peptides useful in regulating immune and nervous systems |
| 01/27/1993 | CN1068329A Pyrazolopyrimidinone antianginal agents |
| 01/26/1993 | US5182378 Sulfate derivatives of galactan extracted from klebsiella |
| 01/26/1993 | US5182300 Furosemide salts |
| 01/26/1993 | US5182280 Derivatives of benzimidazole and their use as antihistamines |
| 01/26/1993 | US5182265 Pharmacologically active peptide derivatives and pharmaceutical preparations containing them |
| 01/26/1993 | US5182257 Anticarcinogenic agents |
| 01/26/1993 | US5182109 Vaccine preparation comprising a bacterial toxin adjuvant |
| 01/26/1993 | CA1313189C Immunomodulatory azaspiranes |
| 01/25/1993 | CA2073913A1 Preparation of fatty acid medicaments |
| 01/24/1993 | CA2070495A1 Substituted 3,4-dihydronaphthalenes, pharmaceutical compositions containing these compounds and processes for the preparation of these compounds and compositions |
| 01/23/1993 | CA2074211A1 Arylalkylamine derivatives |
| 01/21/1993 | WO1993001213A1 Allergenic proteins and peptides from japanese cedar pollen |
| 01/21/1993 | WO1993001181A1 Substituted indoles as anti-aids pharmaceuticals |
| 01/21/1993 | WO1993001170A1 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 01/21/1993 | WO1993001169A2 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/21/1993 | WO1993001165A2 Aromatic compounds, compositions containing them and their use in therapy |
| 01/21/1993 | WO1993000923A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 01/21/1993 | WO1993000917A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 01/21/1993 | WO1992020811A3 Cloning and expression of human islet glutamic acid decarboxylase autoantigen |
| 01/21/1993 | CA2113190A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 01/21/1993 | CA2112913A1 Allergenic proteins and peptides from japanese cedar pollen |
| 01/21/1993 | CA2112473A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 01/21/1993 | CA2110725A1 Aromatic compounds, compositions containing them and their use in therapy |
| 01/21/1993 | CA2110514A1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/20/1993 | EP0523948A2 Method for improving the cancer cell-killing activity of lymphocytes |
| 01/20/1993 | EP0523046A1 2-anilino phenylacetic acid derivatives as inhibitors of pla 2? and lipoxygenase |
| 01/20/1993 | EP0359739B1 Tranforming growth factor-beta |
| 01/20/1993 | CN1068118A Imidazo(2,1-b)(3) benzazeping derivatives, compositions and method of use |
| 01/20/1993 | CN1068116A Imidazo(1,2-a)(pyrrolo, thieno or furano)(3,2-d)azepine derivatives, compositions and methods of use |
| 01/19/1993 | USRE34165 Pentapeptide immunoregulators |
| 01/19/1993 | US5180743 Treatment of rheumatoid arthritis, ant venom extract |
| 01/19/1993 | US5180742 Lipoxygenase Inhibitors |
| 01/19/1993 | US5180739 Use of 3-oxygermylpropionic acid to treat and prevent diabetes-dependent type of autoimmune diseases |
| 01/19/1993 | CA1312860C Process for preparation of aloe products |
| 01/13/1993 | EP0522091A1 Multiple sclerosis t-cell receptor |
| 01/13/1993 | EP0522000A1 5-lipoxygenase inhibitors |
| 01/12/1993 | US5179104 Multistage process for forming viricides |
| 01/12/1993 | US5179089 Isoquinoline compounds, compositions and use |
| 01/12/1993 | US5179087 Antibody inhibitors |
| 01/12/1993 | US5178865 Chinese herbal extracts in the treatment of hiv related disease in vitro |
| 01/12/1993 | US5178855 Treatment of luekocyte dysfunction with GM-CSF |
| 01/12/1993 | US5178852 Cosmetic and pharmaceutical compositions containing lipophilic derivatives of benzylidenecamphor and new lipophilic derivatives of benzylidenecamphor |
| 01/07/1993 | WO1993000431A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | WO1993000362A1 New peptides (didemnins), their preparation and their use |
| 01/07/1993 | WO1993000342A1 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract |
| 01/07/1993 | WO1993000335A1 Tetrahydrobenzazepine derivatives which inhibit lipoxygenase |
| 01/07/1993 | WO1993000331A1 Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
| 01/07/1993 | WO1993000111A1 Monoclonal antibody to lymphocyte-associated cell surface protein |
| 01/07/1993 | WO1993000110A1 Method of stimulating immune response |
| 01/07/1993 | WO1993000077A1 Orally administrable therapeutic proteins and method of making |
| 01/07/1993 | WO1992021313A3 Novel immunosuppressive compounds |
| 01/07/1993 | WO1992017173A3 Use of riboflavin for treating hiv-related diseases, herpes, retinitis pigmentosa and malaria |
| 01/07/1993 | EP0390849B1 Methyl cellulose pharmaceutical composition |
| 01/07/1993 | CA2580812A1 Ctla4 receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | CA2109705A1 Method of stimulating immune response |
| 01/06/1993 | CN1067655A Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
| 01/06/1993 | CA2072676A1 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/05/1993 | US5177079 Antiallergen, antiulcer |
| 01/05/1993 | US5177002 Glycosidases |
| 01/05/1993 | US5177001 In vitro enzymatic conversion of glycosylated mammalian vitamin D-binding protein to a potent macrophage activating factor |
| 01/05/1993 | CA1312336C Aromatic polycyclic derivatives, their preparation process and their use in human and veterinary medicine as well as in cosmetics |